Insider sale
ACHILLES THERAPEUTICS PLC
$209.7K
169.06K shares
What this filing means
ALI IRAJ plans to sell 169.06K shares of ACHILLES THERAPEUTICS PLC valued at approximately $209.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/6/2025ACC: 0002055315-25-000001
169.06K
Shares to sell
$209.7K
Approx. market value
169.06K
Acquired (3 months)
4
Planned
Securities Acquired — Last 3 Months4
Option scheme
Sell to cover transaction
2/1/2023
246.00Option scheme
Sell to cover transaction
2/1/2023
50KOption scheme
Sell to cover transaction
2/1/2023
50KOption scheme
Sell to cover transaction
2/1/2023
68.81KTotal acquired169.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/1/2023 | Option scheme Sell to cover transaction | 246.00 | — |
2/1/2023 | Option scheme Sell to cover transaction | 50K | — |
2/1/2023 | Option scheme Sell to cover transaction | 50K | — |
2/1/2023 | Option scheme Sell to cover transaction | 68.81K | — |
| Total | 169.06K | ||
Planned & Completed Dispositions4
NasdaqPlanned
Units to sell
68.81K
Market value
$80.6K
2/4/2025
NasdaqPlanned
Units to sell
50K
Market value
$64.3K
2/4/2025
NasdaqPlanned
Units to sell
246.00
Market value
$291.81
2/4/2025
NasdaqPlanned
Units to sell
50K
Market value
$64.5K
2/4/2025
Total
Units
169.06K
Value
$209.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/4/2025 | 68.81K | $80.6K | Nasdaq | Planned |
2/4/2025 | 50K | $64.3K | Nasdaq | Planned |
2/4/2025 | 246.00 | $291.81 | Nasdaq | Planned |
2/4/2025 | 50K | $64.5K | Nasdaq | Planned |
| Total | 169.06K | $209.7K | ||